Blood transfusion profile of Beta-Thalassemia Major patients attending a tertiary care hospital

Authors

  • Mallikarjun Adiveppa Pattanashetti Assistant Professor, Department of Pathology, S.Nijalingappa Medical College and HSK Hospital and Medical Research Centre, Bagalkot, Karnataka
  • Ganga S Pilli Professor, Department of Pathology, J N Medical College ,Belagavi , Karnataka
  • Laxmi Pattanashetti Assistant Professor, Department of Pharmacology , KLE College of Pharmacy, Belagavi, Karnataka

Keywords:

β thalassemia, transfusion, chelation.

Abstract

Background: Beta (β) thalassemia major is most common monogenic disorder in the world. Around 1,00,000 children are born each year with the severe homozygous state of the disease in India. The objectives of this study was to assess clinical data and the blood transfusion profile of Beta thalassemia major patients attending tertiary care hospital. This was undertaken as very few studies have been done in this region of the vast country.

Methods: The study was done at a tertiary care teaching hospital from January 2014 to December 2014. Universal sampling method was used and 35 β thalassemia major patients who received  blood transfusions at 2 to 4 weeks interval in the hospital were included in this study. Clinical details and blood transfusion record was collected on proforma for all patients and data interpreted.

Result: Males (80%) outnumbered females (20%) with male to female ratio of 4:1. Nearly half of the study population was aged between 10 to 12 years (51.43). Majority of the patients had one blood transfusion per month (91.43%) and were on chelation therapy (71.43%). Majority of the patients received 100 to 125 blood transfusions during their lifetime        (28.57 %). Least number of blood transfusions of more than 250 transfusions was taken by one patient (2.86 %).

Conclusion: The present study describes the transfusion profile of β thalassemia major patients attending the tertiary care hospital and emphasizes on  maintenance of transfusion record of b thalassemia major patients for better management of these patients.

 

DOI: 10.21276/APALM.1269

References

1. Cao A, Galanello R. Beta thalassemia. Genet Med 2010;12:61-76.
2. Management of birth defects and haemoglobin disorders: Report of a Joint WHO-March of Dimes Meeting. Geneva: World Health Organization; 2006.
3. Sarnaik, AS. Thalassemia and Related Hemoglobinopathies. Indian J Pediatr 2005;72(4):319-24.
4. Chern JP, Su S, Lin KH, Chang SH, Lu MY, Jou ST, et al. Survival, mortality and complications in patients with beta thalassaemia major in northern Taiwan. Pediatr Blood Cancer 2006;47:432-7.
5. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Pediatr Diabetes 2004;5:126-32.
6. Najafipour F, Sorkhabi RS, Aghai NH, Zareizadeh M, Bahrami A. Importance of OGTT for diagnosis of Diabetes in thalassemia major patients J Gorgan Uni Med Sci 2008;10(3):71-6.
7. Mallik S, Chatterjee C, Mandal PK, Sardar JC, Ghosh P, Manna N. Expenditure to Treat Thalassaemia: An Experience at a Tertiary Care Hospital in India. Iranian J Publ Health 2010;39(1):78-84.
8. Rai ME, Tanoli ZM, Gandapur ASK. Clinical spectrum of patients of beta thalassemia: a review of fifty four patients. Glomal J Medical sciences 2005;3(2):55-60.
9. Guidelines for the Clinical Management of Thalassaemia. 2nd Revised ed., No. 9, Nicosia (CY): Thalassaemia International Federation; 2008.

Downloads

Additional Files

Published

19-04-2017

How to Cite

1.
Pattanashetti MA, Pilli GS, Pattanashetti L. Blood transfusion profile of Beta-Thalassemia Major patients attending a tertiary care hospital. Ann of Pathol and Lab Med [Internet]. 2017 Apr. 19 [cited 2025 Feb. 5];4(2):A208-211. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm1269

Issue

Vol. 4 No. 2 (2017)

Section

Original Article

License

Copyright (c) 2017 Mallikarjun Adiveppa Pattanashetti, Ganga S Pilli, Laxmi Pattanashetti

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).